Discontinuation report STRATTERA
Report ID | 171485 |
Drug Identification Number | 02262827 |
Brand name | STRATTERA |
Common or Proper name | atomoxetine capsules |
Company Name | ELI LILLY CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ATOMOXETINE |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | Blister package of 28 capsules |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2023-09-20 |
Actual discontinuation date | 2023-09-21 |
Remaining supply date | 2023-09-20 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-09-25 | English | Compare |
v8 | 2023-09-15 | French | Compare |
v7 | 2023-09-15 | English | Compare |
v6 | 2023-07-14 | French | Compare |
v5 | 2023-07-14 | English | Compare |
v4 | 2023-05-01 | French | Compare |
v3 | 2023-05-01 | English | Compare |
v2 | 2022-10-11 | French | Compare |
v1 | 2022-10-11 | English | Compare |
Showing 1 to 9 of 9